EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study

Evelyne Marie Piret iD, Heather Palis, Alexis Crabtree, JinCheol Choi, Kora DeBeck, Kanna Hayashi, Michael R Law, M-J Milloy

Drug and Alcohol Review · 2026-07 · 45 (5)

DOI: 10.1111/dar.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Review, online erschienen am 10.06.2026. Verfasst von Evelyne Marie Piret und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Population and Public Health, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Gabapentin, Analgesics, Opioid, Analgesics, Pain. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, CIHR, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gabapentin is widely prescribed off‐label to treat pain. However, there are concerns about the proliferation of medical and non‐medical use, and the potential increased risk of overdose death associated with concurrent opioid use. Despite these considerations, prescription gabapentin use among people who use unregulated drugs is uncharacterised in Canada. Therefore, we investigated trends and factors associated with being prescribed gabapentin for pain among community‐recruited people who use opioids.

Methods

Data were derived from three prospective cohort studies of people who use unregulated drugs in Vancouver, Canada, restricted to periods of opioid use (i.e., unregulated use, non‐medical use, and/or opioid agonist treatment). We characterised factors associated with reporting gabapentin for pain between 2014 and 2020 using multivariable generalised estimating equations. Trends in self‐reported prescription (2014–2020) and non‐medical (2016–2024) gabapentin use were explored.

Results

Between 2014 and 2020, we included 10,999 observations from 2039 participants who had a baseline median age of 38 years and were 62.4% male and 57.5% White. Gabapentin prescriptions for pain were reported by 255 (12.5%) participants. Observations reporting a neuropathic pain diagnosis had 3.54 times the adjusted odds (95% CI 2.81, 4.46) of being prescribed gabapentin. From 2014 to 2020, the prevalence of gabapentin prescriptions rose from 5.4% to 7.8%. Non‐medical gabapentin use remained low. Discussion and Conclusions Among people who use opioids, we observed an increase in gabapentin prescriptions for pain between 2014 and 2020. Gabapentin prescriptions were strongly associated with reporting a neuropathic pain diagnosis. Rates of non‐medical gabapentin use were substantially lower than rates reported internationally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GabapentinAnalgesics, OpioidAnalgesicsPainDrug PrescriptionsHumansMaleFemaleAdultLongitudinal StudiesPrevalenceProspective StudiesMiddle AgedCanadaOff-Label Use

Stichwörter der Autor:innen

chronic paingabapentinneuropathic painnon‐medical useopioid

Substanzen

GabapentinAnalgesics, OpioidAnalgesics

Autor:innen und Institutionen

  • School of Population and Public Health, University of British Columbia, Vancouver, Canada.
  • British Columbia Centre on Substance Use, Vancouver, Canada.
  • BC Centre for Disease Control, Vancouver, Canada.
  • School of Public Policy, Simon Fraser University, Vancouver, Canada.
  • Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

ORCID-Profile: Evelyne Marie Piret

Förderung

  • NIDA NIH HHS
  • CIHR
  • NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research

Zitieren

APA

Piret, E. M., Palis, H., Crabtree, A., Choi, J., DeBeck, K., Hayashi, K., Law, M. R., & Milloy, M. J. (2026). Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study. Drug and Alcohol Review, 45(5). https://doi.org/10.1111/dar.70186

Vancouver

Piret EM, Palis H, Crabtree A, Choi J, DeBeck K, Hayashi K, et al. Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study. Drug and Alcohol Review. 2026;45(5). doi:10.1111/dar.70186

BibTeX
@article{Piret2026,
  author = {Piret, Evelyne Marie and Palis, Heather and Crabtree, Alexis and Choi, JinCheol and DeBeck, Kora and Hayashi, Kanna and Law, Michael R and Milloy, M-J},
  title = {Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {5},
  doi = {10.1111/dar.70186}
}
Kostenlos starten →